Tsai C.-W.FENG-JUNG YANGHuang C.-C.Kuo C.-C.YUNG-MING CHEN2020-12-242020-12-2420131492-7535https://www.scopus.com/inward/record.uri?eid=2-s2.0-84872673877&doi=10.1111%2fj.1542-4758.2012.00704.x&partnerID=40&md5=77e855799a9561847210b154e38ce85dhttps://scholars.lib.ntu.edu.tw/handle/123456789/531583[SDGs]SDG3deferasirox; deferoxamine mesylate; adult; case report; chronic kidney disease; drug dose titration; hemodialysis patient; human; iron overload; kidney failure; letter; malaise; paroxysmal nocturnal hemoglobinuria; prognosis; refractory anemia; renal replacement therapy; Benzoates; Hemochromatosis; Humans; Iron Chelating Agents; Iron Overload; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Triazolesletter10.1111/j.1542-4758.2012.00704.x225490062-s2.0-84872673877